|
NCI Issues Clinical Announcement for Preferred Method of Treatment for Advanced Ovarian Cancer
Right
Click to Download MP3 File
Brief Description:
The National Cancer Institute announces that after a series of trials comparing chemotherapy treatment, they recommend treating advanced ovarian cancer by delivering anticancer drugs via two methods — by IV and directly into the abdomen after surgery.
Transcript:
Akinso: For years, the standard treatment for ovarian cancer has been surgical removal of the tumor, followed by chemotherapy. Now, the National Cancer Institute announces that after a series of trials comparing chemotherapy treatment, they recommend treating advanced ovarian cancer by delivering anticancer drugs via two methods — by IV and directly into the abdomen after surgery. Dr. Ted Trimble, of NCI's Cancer Therapy Evaluation Program says these combined methods extend the overall survival for women with this condition by about a year.
Trimble: The improvement in survival was at a minimum of 12 months, the most recent trial saw an improvement of 16 months improved survival. So based on the results of these three trials the NCI January 5th issued a Clinical Announcement recommending that doctors and patients with newly diagnosed ovarian cancer strongly considered the possibilities of some of the chemotherapy given directly into the abdominal cavity.
Akinso: The clinical announcement to surgeons and other medical professionals who treat women with ovarian cancer was made with the support of six professional societies and advocacy groups. It coincides with publication in the New England Journal of Medicine of the results of a large clinical trial by Doctor Deborah Armstrong, medical oncologist and an associate professor at Johns Hopkins Kimmel Cancer Center in Baltimore, Md., and her colleagues in an NCI-supported research network known as the Gynecologic Oncology Group. For more information, visit www.cancer.gov. This is Wally Akinso at the National Institutes of Health Bethesda Maryland.
|
